IBDEI0VV ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15484,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,15484,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,15485,0)
 ;;=601.0^^81^944^44
 ;;^UTILITY(U,$J,358.3,15485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15485,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,15485,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,15485,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,15486,0)
 ;;=590.10^^81^944^46
 ;;^UTILITY(U,$J,358.3,15486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15486,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,15486,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,15486,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,15487,0)
 ;;=590.00^^81^944^47
 ;;^UTILITY(U,$J,358.3,15487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15487,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,15487,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,15487,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,15488,0)
 ;;=788.7^^81^944^54
 ;;^UTILITY(U,$J,358.3,15488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15488,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,15488,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,15488,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,15489,0)
 ;;=131.02^^81^944^57
 ;;^UTILITY(U,$J,358.3,15489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15489,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,15489,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,15489,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,15490,0)
 ;;=597.80^^81^944^55
 ;;^UTILITY(U,$J,358.3,15490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15490,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,15490,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,15490,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,15491,0)
 ;;=788.41^^81^944^58
 ;;^UTILITY(U,$J,358.3,15491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15491,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,15491,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,15491,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,15492,0)
 ;;=788.31^^81^944^62
 ;;^UTILITY(U,$J,358.3,15492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15492,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,15492,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,15492,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,15493,0)
 ;;=788.20^^81^944^63
 ;;^UTILITY(U,$J,358.3,15493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15493,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,15493,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,15493,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,15494,0)
 ;;=112.2^^81^944^66
 ;;^UTILITY(U,$J,358.3,15494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15494,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,15494,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,15494,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,15495,0)
 ;;=600.01^^81^944^5
 ;;^UTILITY(U,$J,358.3,15495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15495,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,15495,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,15495,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,15496,0)
 ;;=600.10^^81^944^40
 ;;^UTILITY(U,$J,358.3,15496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15496,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,15496,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,15496,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,15497,0)
 ;;=585.9^^81^944^8
 ;;^UTILITY(U,$J,358.3,15497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15497,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,15497,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,15497,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,15498,0)
 ;;=788.64^^81^944^59
 ;;^UTILITY(U,$J,358.3,15498,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0VV
